Prenatal Diagnosis: Understanding the Identification of Medical Conditions Before Birth
Prenatal diagnosis is defined as the process of identifying a medical condition in the baby before birth. This procedure can be carried out during pregnancy or, in the context of in vitro fertilization, even before embryo implantation.
Key Difference: Prenatal Screening vs. Prenatal Diagnosis
Prenatal screening is an initial evaluation designed to determine if a fetus has an increased risk of having any abnormality. In developed nations, screening is routinely offered to all pregnant women, typically performed during the first and second trimesters (up to week 26 of gestation). This process combines fetal ultrasound. ultrasound with maternal blood tests. The abnormalities abnormalities that are examined are those associated with significant morbidity or mortality (morbidity/mortality).
On the other hand, prenatal diagnosis confirms a specific medical condition. It uses advanced tools such as genetic testing, geneticimmunohistochemistry techniques immunohistochemistry and examination via microscopy electron microscopy. As with screening, prenatal diagnosis is reserved for conditions that carry a high probability of significant morbidity or mortality.
Fundamental Purposes of Prenatal Diagnosis
Carrying out prenatal diagnosis addresses several crucial needs for family planning and medical care:
- Offering prospective parents the informed option to continue or terminate the pregnancy when a severe hereditary skin disease is diagnosed.
- Facilitating optimal preparation for birth and initial care of the neonate. This includes:
- Ensuring parents receive appropriate genetic and psychological counseling and prepare emotionally.
- Anticipating possible complications during delivery, such as an increased risk of failure in the Progress labor progression Ichthyosis linked to the X chromosome.
- Coordinating the delivery to take place in a suitable medical facility, with immediate access to a Neonatal Intensive Care Unit (Neonatal).
Skin Conditions Diagnosable Before Birth
Various hereditary dermatological conditions are suitable candidates for prenatal diagnosis. These include:
- Epidermolysis bullosa.
- Icthyotic disorders.
- Oculocutaneous albinism.
- Ectodermal dysplasia Ectodermal dysplasia.
Although the gene gene , originating from a mutation causing many other hereditary dermatoses is known, prenatal testing should only be performed when the disorder presents high associated morbidity or mortality.
Relevance of Fetal Sex in Prenatal Diagnosis of Skin Diseases
Determination of the fetal sex sex acquires critical importance when performing prenatal diagnosis for certain hereditary skin conditions. A notable example is incontinentia pigmenti, an X-linked dominant condition that is often fatal in male fetuses, while affecting females to varying degrees of severity. Similarly, X-linked ichthyosis reveals distinct inheritance patterns based on sex.
In summary, prenatal diagnosis offers invaluable information, allowing for more informed decision-making and precise medical preparation for the birth of a baby with potential complex dermatological conditions.
Prenatal Diagnosis of Skin Diseases in Males
In the case of males, hereditary skin diseases may manifest at birth. However, the female sex, if a carrier, usually does not show involvement or may develop asymptomatic corneal opacities.
Methods and Appropriate Timing for Prenatal Diagnosis
Below are the tests used for the prenatal diagnosis of skin diseases in the following table:
| Method | Skin Disorders Evaluated | Timing | Technique |
|---|---|---|---|
| Preimplantation Genetic Diagnosis | Harlequin Ichthyosis; Severe Ectodermal Dysplasia Syndromes | 3 days after In Vitro Fertilization (IVF) | Genetic analysis in embryos after fertilization. Only embryos confirmed without the disorder are implanted in the uterus. |
| Chorionic Villus Sampling (CVS) | Epidermolysis Bullosa; Oculocutaneous Albinism | Weeks 10 to 13 of gestation | Collection of cells from the placental villi using a needle inserted through the cervix or transabdominally under ultrasound guidance. Fetal DNA DNA is extracted and analyzed looking for known genetic mutations. |
| Amniocentesis | Epidermolysis Bullosa; Oculocutaneous Albinism | Starting from the 14th week of pregnancy | Obtaining fetal cells from the amniotic fluid with a needle inserted transabdominally under ultrasound guidance. The presence of known genetic mutations in fetal DNA is investigated. |
| Skin Fetal Skin Biopsy | Skin conditions with unknown genetic mutation | Starting from the 19th week of gestation (once fetal skin has formed) | A puncture biopsy of the fetal skin is performed under ultrasound guidance. The sample is examined using immunohistochemistry and Use of excision via electron microscope Maternal Serum Analysis. |
| X-linked Ichthyosis (detected by low levels of Ue3) sickness During the second trimester (Weeks 14 to 26) | Measurement of maternal serum levels of hormones and | specific proteins through a blood test to assess the risk of various conditions. | Harlequin Ichthyosis (suggested by echogenic amniotic fluid, joint contractures, and facial dysmorphism) proteins Starting from 12 weeks of gestation. |
| Ultrasound | A transabdominal ultrasound is performed to support the diagnosis. It is especially useful for identifying conditions in the absence of a family history. | Potential Complications Associated with Prenatal Diagnosis | The potential complications of prenatal diagnosis vary significantly depending on the invasive technique used:. |
Risk of misdiagnosis due to technical difficulty and the small number of cells available for genetic analysis.
It has lower pregnancy rates compared to In Vitro Fertilization (IVF) that does not include prenatal diagnosis.
Preimplantation Genetic Diagnosis
- It involves a very high economic cost.
- CVS, Amniocentesis, and Fetal Skin Biopsy.
- A reduced risk of fetal loss (estimated between 1% and 3%).
Possibility of amniotic fluid loss.
- Risk of Rh Factor sensitization in Rh-negative mothers.
- Fetal Skin Biopsy.
- Risk of sensitization May result in scarring (usually mild) in the newborn.
If performed before fetal skin has fully developed, results may be inconclusive.
- Is Treatment of the Skin Condition Viable Before Birth?.
- Currently, there is no established method to treat hereditary skin diseases while the baby is in the womb. However, future advances in fetal medicine may open the possibility of applying intrauterine treatments in the future.
The choice of prenatal diagnosis method is crucial and must be carefully weighed considering the risk of complication versus the need to obtain genetic confirmation before birth.
Epidermal blistering.
Albinism oculocutaneous.
